Ngs Pharma Ltd in Colchester, CO6 3JB

Description

Data updated on: 01-11-2023

Ngs Pharma Ltd has been in the business for at least thirteen years. Started with Companies House Reg No. 07871679 in the year 2011, the firm is located at 39 Chapel Road, Colchester CO6 3JB. The enterprise's principal business activity number is 47730: Dispensing chemist in specialised stores. Ngs Pharma Limited filed its account information for the financial year up to 2022-03-31. The business latest confirmation statement was filed on 2022-12-05.

As for this particular limited company, a variety of director's tasks have so far been met by Nikunj S. who was formally appointed in 2011 in December.

Nikunj S. is the individual with significant control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency
Net Worth	468	4 561

Balance Sheet
Cash Bank On Hand		387 061	435 999	438 175	392 070	298 091	505 987	581 705	784 310
Current Assets	502 978	687 432	763 861	762 471	837 309	814 465	945 521	1 038 564	1 190 789
Debtors	215 547	237 985	260 887	248 968	359 359	423 464	345 375	362 656	316 287
Net Assets Liabilities		4 562	113 522	241 248	423 810	471 888	592 535	771 260	917 300
Other Debtors		27 059	30 705	32 267	33 797	164 295	169 261	169 006	200 010
Property Plant Equipment		5 703	4 169	16 223	10 655	5 610	927	1 459
Total Inventories		62 386	66 975	75 328	85 880	92 910	94 159	94 203	90 192
Cash Bank In Hand	217 387	387 061
Intangible Fixed Assets	167 500
Stocks Inventory	70 044	62 386
Tangible Fixed Assets	9 479	5 703

Capital & Reserves
Called Up Share Capital	100	100
Profit Loss Account Reserve	368	4 461
Shareholder Funds	468	4 561

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets		670 000	670 000	670 000	670 000	670 000	670 000	670 000
Accumulated Depreciation Impairment Property Plant Equipment		9 401	12 852	16 978	22 546	28 161	33 452	33 902	12 846
Bank Borrowings Overdrafts		219 410	177 519	138 525	94 683	45 488	93 227	50 000	29 433
Corporation Tax Payable		19 723	45 912	39 156	54 003
Creditors		219 410	177 519	138 525	94 683	45 488	93 227	50 000	29 433
Increase From Depreciation Charge For Year Property Plant Equipment			3 451	8 301	5 568	5 615	5 291	450	577
Intangible Assets Gross Cost		670 000	670 000	670 000	670 000	670 000	670 000	670 000
Net Current Assets Liabilities	83 545	218 268	286 872	363 550	507 838	511 766	684 835	819 801	945 254
Number Shares Issued Fully Paid			100	100			100	100	100
Other Creditors		266 562	240 504	157 745	67 310	46 661	30 749	22 121	23 343
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment				4 175
Other Disposals Property Plant Equipment				4 175
Other Taxation Social Security Payable				3 607	54 182	22 550	40 031	51 996	44 429
Par Value Share		1	1	1			1	1	1
Property Plant Equipment Gross Cost		15 105	17 021	33 201	33 201	33 771	34 379	35 361	12 846
Total Additions Including From Business Combinations Property Plant Equipment			1 916	20 355		570	608	982	597
Total Assets Less Current Liabilities	260 524	223 971	291 041	379 773	518 493	517 376	685 762	821 260	946 733
Trade Creditors Trade Payables		134 514	142 209	150 049	159 615	184 960	142 473	144 646	166 363
Trade Debtors Trade Receivables		210 926	230 182	216 701	325 562	259 169	176 114	193 650	116 277
Average Number Employees During Period					9	10	7	7	7
Fixed Assets	176 979	5 703			10 655	5 610	927	1 459	1 479
Dividends Paid							60 000
Profit Loss							160 647
Creditors Due After One Year	260 056	219 410
Creditors Due Within One Year	419 433	469 164
Intangible Fixed Assets Aggregate Amortisation Impairment	502 500	670 000
Intangible Fixed Assets Amortisation Charged In Period		167 500
Intangible Fixed Assets Cost Or Valuation		670 000
Number Shares Allotted		100
Share Capital Allotted Called Up Paid	100	100
Tangible Fixed Assets Cost Or Valuation		15 105
Tangible Fixed Assets Depreciation	5 625	9 402
Tangible Fixed Assets Depreciation Charged In Period		3 777

Company staff

Nikunj S.

Role: Director

Appointed: 05 December 2011

Latest update: 29 February 2024

People with significant control

Nikunj S.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	19 December 2023
Confirmation statement last made up date	05 December 2022

Annual Accounts 15 November 2016
Start Date For Period Covered By Report	2015-04-01
End Date For Period Covered By Report	2016-03-31
Date Approval Accounts	15 November 2016
Annual Accounts
Start Date For Period Covered By Report	2016-04-01
End Date For Period Covered By Report	2017-03-31
Annual Accounts
Start Date For Period Covered By Report	2017-04-01
End Date For Period Covered By Report	2018-03-31
Annual Accounts
Start Date For Period Covered By Report	2018-04-01
End Date For Period Covered By Report	2019-03-31
Annual Accounts
Start Date For Period Covered By Report	01 April 2019
End Date For Period Covered By Report	31 March 2020
Annual Accounts
Start Date For Period Covered By Report	01 April 2020
End Date For Period Covered By Report	31 March 2021
Annual Accounts
Start Date For Period Covered By Report	01 April 2021
End Date For Period Covered By Report	31 March 2022
Annual Accounts
Start Date For Period Covered By Report	01 April 2022
End Date For Period Covered By Report	31 March 2023

Ngs Pharma Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Nikunj S.

People with significant control

Nikunj S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies